• 2
  • 3
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4

Why machines can't be human enough?

From automobiles to accessories, computers to handsets, technology has only one thing to do-making things more human. When machines get to become human, isn’t it ironic that humans tend to be more like machines? Thankfully enough, our question puts our products in a different context- Behave like a human , work like a machine. Questions that result in products of difference. Our state-of-the-art research centre with multiple facets work with this single agenda- Asking questions that make significant difference to human lives.

As part of a new awakening in the In-Vitro Diagnostic industry, Meril Diagnostics has ushered in a wide array of innovative diagnostic products. Emerging from a lineage of successful business enterprise, Meril Diagnostics is a part of the healthcare arm of the multi-million dollar MNC group. The company is based out at Vapi in the state of Gujarat, which is located 150kms from Mumbai, the commercial hub of India.

A state-of-the-art, 300,000 sq. foot manufacturing, research and development facility is testimony to the commitment and vision of Meril’s future plan to cater to the global IVD market and become a leader in Indian IVD industry by 2018.

With cutting-edge R&D and manufacturing facilities, our commitment to expanding access to healthcare has never been more far-reaching. This focus helps ensure customer insights and inspires us to develop market-appropriate, value-driven solutions that support the healthcare industry around the world.

Ensuring ‘accuracy and precision’, each of our products is put through several stringent quality control protocols, that enhances our as well as the end-user’s confidence.

For the first time in the IVD segment, a new concept has been introduced to make each product segment easy to identify through its unique color coded packaging system.

Meril Diagnostics is available with a complete range of analyzers and reagents for Clinical Biochemistry, Hematology, Immunology (ELISA & CLIA), Rapids, Coagulation, Critical Care, Diabetes Management and Lab Consumables . The company has a clear-cut road map to being an industry leader in Rapid Immunology assays through complete integration of R&D and manufacturing.

Currently two-thirds of the Indian IVD market requirement is still catered by foreign companies and their products. Meril Diagnostics’ future plans include manufacturing of 80% of its products in India and catering them worldwide. The company’s strategy of manufacturing analyzers and reagents is aptly supported by a team of highly qualified and experienced research & development personnel. The team commenced its projects in 2011 and launched several analyzers and reagents all ‘Designed & Developed by Meril’.

In its quest for innovation, Meril has been successful in completing the in-house development of Hematology Analyzer and Controls. It is part of Meril’s mission to create a definitive change in the way the world perceives the Indian IVD market as not just a consumer but also as a manufacturer, capable of supplying high quality diagnostic products worldwide.

Meril has also collaborated with the world leaders in Immunology processors and Oncology kits from Dynex Technologies (USA), Gold Standard Diagnostics (USA) and Fujirebio Diagnostics (USA) respectively.

Meril Diagnostics has more than 400 dedicated employees from the field of diagnostic Sales, Marketing, Application, Engineering, R&D, Legal, Finance, Regulatory, and Supply Chain to provide complete support and satisfaction to its customers. Partnering growth efforts with more than a dozen CFAs and above 150 distributors Meril Diagnostics is committed to providing prompt service under the desired guidance of temperature sensitivity. The Customer Support Team offers 24x7 assistance to handle customer queries and scientific support.